Eric Dobmeier

Affiliations

  • at Janux Therapeutics Inc. (JANX), 2025-06-13
  • at Jade Biosciences Inc. (JBIO), 2025-05-01
  • at Structure Therapeutics Inc. (GPCR), 2024-06-27
  • at Atara Biotherapeutics Inc. (ATRA), 2023-11-14
  • President, Ceo at Chinook Therapeutics Inc. (KDNY), 2023-08-11
  • Director at Adaptive Biotechnologies Corp (ADPT), 2021-02-18
  • Director at Versartis Inc. (VSAR), 2017-12-22
  • Chief Operating Officer at Seattle Genetics Inc (SGEN), 2017-12-07
  • Director at Stemline Therapeutics Inc (STML), 2017-06-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ATRA $0.23 446,825 $101,339.91 563,325 2023-11-10 Filing
KDNY $13.03 5,000 $65,147.50 205,880 2022-05-25 Filing
KDNY $12.00 2,000 $24,000.00 109,837 2021-09-20 Filing
KDNY $12.00 3,000 $36,000.00 107,837 2021-08-19 Filing
KDNY $11.74 7,000 $82,163.20 104,837 2021-08-18 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KDNY $22.26 1,200 $26,711.04 301,138 2023-04-24 Filing
KDNY $21.58 23,800 $513,527.84 302,338 2023-04-24 Filing
KDNY $23.75 8,097 $192,291.60 301,138 2023-02-10 Filing
KDNY $24.68 7,688 $189,756.75 288,987 2023-01-31 Filing
KDNY $24.54 25,000 $613,612.50 271,676 2023-01-30 Filing